Krystal Biotech, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $310.8M
Liabilities Breakdown FY2020
Total Liabilities: $18.8M
Asset Breakdown
Total Assets: $310.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $268.3M | 86.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $30.9M | 9.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $11.7M | 3.8% |
Liabilities Breakdown
Total Liabilities: $18.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.1M | 11.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.7M | 88.8% |